Erratum

Neuropsychobiology 2009;60:67–72 72 22 Martorell L, Virgos C, Valero J, Coll G, Figuera L, Joven J, Pocovi M, Labad A, Vilella E: Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it. Mol Psychiatry 2001; 6: 307– 310. 23 Kimura T, Shono M, Yokota S, Ishizuka K, Watanabe M, Takamatsu J, Miyakawa T: Apolipoprotein E epsilon4 and tardive dyskinesia in a Japanese population. J Psychiatr Res 2000;34: 329–332. 24 Durany N, Riederer P, Cruz-Sanchez FF: Apolipoprotein E genotype in Spanish schizophrenic patients. Psychiatr Genet 2000; 10: 73–77. 25 Kimura T, Yokota S, Igata-Yi R, Shono M, Takamatsu J, Miyakawa T: Apolipoprotein E epsilon2 allele and early onset schizophrenia. Neurosci Lett 1997; 231: 53–55. 26 Igata-Yi R, Igata T, Ishizuka K, Kimura T, Sakamoto S, Katsuragi S, Takamatsu J, Miyakawa T: Apolipoprotein E genotype and psychosis. Biol Psychiatry 1997; 41: 906–908. 27 Moberg PJ, Arnold SE, Roalf DR, Balderston CC, Abbazia J, Kohler CG, Gur RE, Turetsky BI: Apolipoprotein E genotype and odor identification in schizophrenia. J Neuropsychiatry Clin Neurosci 2006; 18: 231–233. 28 Xu MQ, St Clair D, He L: Meta-analysis of association between ApoE epsilon4 allele and schizophrenia. Schizophr Res 2006; 84: 228–235. 29 Halford J, Mazeika G, Slifer S, Speer M, Saunders AM, Strittmatter WJ, Morgenlander JC: APOE2 allele increased in tardive dyskinesia. Mov Disord 2006; 21: 540–542. 30 Kampman O, Anttila S, Illi A, Mattila KM, Rontu R, Leinonen E, Lehtimäki T: Apolipoprotein E polymorphism is associated with age of onset in schizophrenia. J Hum Genet 2004; 49: 355–359. 31 Liu W, Breen G, Zhang J, Li S, Gu N, Feng G, Bai S, Shen T, Yu A, Xue H, St Clair D, He L: Association of APOE gene with schizophrenia in Chinese: a possible risk factor in times of malnutrition. Schizophr Res 2003; 62: 225– 230. 32 Hong CJ, Yu YW, Lin CH, Song HL, Lai HC, Yang KH, Tsai SJ: Association study of apolipoprotein E epsilon4 with clinical phenotype and clozapine response in schizophrenia. Neuropsychobiology 2000; 42: 172–174. 33 Kimura T, Shono M, Yokota S, Igata-Yi R, Takamatsu J, Miyakawa T: Apolipoprotein E epsilon3 allele is not a risk factor of schizophrenia: a study of 314 Japanese patients. Neuropsychobiology 2000; 42: 66–68. 34 Thibaut F, Van Der Elst A, Campion D, Martin C, Coron B, Dollfus S, Frebourg TH, Petit M: Apolipoprotein E-varepsilon4 frequency in deficit schizophrenia. Eur Psychiatry 1999; 14: 148–151. 35 Arnold SE, Joo E, Martinoli MG, Roy N, Trojanowski JQ, Gur RE, Cannon T, Price RA: Apolipoprotein E genotype in schizophrenia: frequency, age of onset, and neuropathologic features. Neuroreport 1997; 8: 1523— 1526.